Depression screening tools in persons with epilepsy: A systematic review of validated tools
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary: Objective: Depression affects approximately 25% of epilepsy patients. However, the optimal tool to screen for depression in epilepsy has not been definitively established. The purpose of this study was to systematically review the literature on the validity of depression‐screening tools in epilepsy. Methods: MEDLINE, EMBASE, and Psyc INFO were searched until April 4, 2016 with no restriction on dates. Abstract, full‐text review and data abstraction were conducted in duplicate. We included studies that evaluated the validity of depression‐screening tools and reported measures of diagnostic accuracy (e.g., sensitivity, specificity, and negative and positive predictive values) in epilepsy. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies Version 2. Medians and ranges for estimates of diagnostic accuracy were calculated when appropriate. Results: A total of 16,070 abstracts were screened, and 38 articles met eligibility criteria. Sixteen screening tools were validated in 13 languages. The most commonly validated screening tool was the Neurological Disorders Depression Inventory for Epilepsy (NDDI‐E) (n = 26). The Mini International Neuropsychiatric Interview (MINI) (n = 19) was the most common reference standard used. At the most common cutpoint of >15 (n = 12 studies), the NDDI‐E had a median sensitivity of 80.5% (range 64.0–100.0) and specificity of 86.2 (range 81.0–95.6). Meta‐analyses were not possible due to variability in cutpoints assessed, reference standards used, and lack of confidence intervals reported. Significance: A number of studies validated depression screening tools; however, estimates of diagnostic accuracy were inconsistently reported. The validity of scales in practice may have been overestimated, as cutpoints were often selected post hoc based on the study sample. The NDDI‐E, which performed well, was the most commonly validated screening tool, is free to the public, and is validated in multiple languages and is easy to administer, although selection of the best tool may vary depending on the setting and available resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Back-translation for cross-cultural research.
Brislin, R. W. (1970) · Journal of Cross-Cultural Psychology · doi:10.1177/135910457000100301 · Cited by 14,091 · cited 2×
“The authors indicated the NDDIE was directly translated from English into the respective language and then backtranslated to ensure reliability between the two versions,15,17,19,23,29,34,37,38 also known as the Brislin Technique.54 Although this step should ensure reliable data for comparison, it must be noted that th…”
MethodThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 1×
“The most validated HADS-D cutpoint of 8, is the cutpoint that is recommended to detect depression in general populations.(52) Although fewer studies validated the HADS-D in persons with epilepsy and the test requires a paid license for administration, theoretically it still may be a beneficial tool for detecting depre…”
BackgroundVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationThe Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Psychiatric comorbidity in epilepsy: a population-based analysis
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J., & Wiebe, S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01222.x · Cited by 1,113
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.246280 · Cited by 984
Cited by
Psychiatric Comorbidities in People With Epilepsy
Mula, M., Kanner, A. M., Jetté, N., & Sander, J. W. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000874 · Cited by 256
Self-citationPsychiatric comorbidities in epilepsy.
Josephson, C. B., & Jetté, N. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1302412 · Cited by 224
“A number of depression screening tools now exist to facilitate the diagnosis of depression in people with epilepsy (Gill et al., 2017).”
BackgroundSelf-citation
Metadata
- Authors
- Gill, S. J., Lukmanji, S., Fiest, K. M., Patten, S. B., Wiebe, S., & Jetté, N.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2017-01-08
- Volume
- 58
- Issue
- 5
- Pages
- 695-705
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2570502014
- Cited by
- 160
- References
- 16
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.